CHAPEL HILL, N.C.--(BUSINESS WIRE)--Nov. 17, 2011--
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to
transforming medicine that transforms lives, announced today that John
R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief
Executive Officer, will present at the Piper Jaffray 23rd
Annual Healthcare Conference on Wednesday, November 30, 2011 at 2:30
p.m. (ET), at The New York Palace Hotel. Dr. Plachetka’s presentation
will be webcast and available for replay on POZEN’s home page at www.pozen.com.
POZEN Inc. is a progressive pharmaceutical company that is transforming
how the healthcare industry addresses unmet medical needs. By utilizing
a unique in-source model and focusing on integrated therapies, POZEN has
successfully developed and obtained FDA approval of two self-invented
products in two years – something almost no other small pharmaceutical
company has done. Funded by these two milestone/royalty streams, POZEN
is now creating a portfolio of cost-effective, evidence-based integrated
aspirin therapies designed to enable the full power of aspirin by
reducing its GI damage.
The Company’s common stock is traded on The NASDAQ Global Market under
the symbol “POZN”. For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
Source: POZEN Inc.
Bill Hodges, 919-913-1030
Stephanie Bonestell, 919-913-1030
Investor Relations & Public Relations